Phase I clinical trials. Medical device post-market surveillance requirements. FDA disclosure issues. To achieve lasting success, biotech/life sciences industry executives must achieve effective communication across a broad spectrum of issues and audiences in biotechnology, pharmaceutical processing, drug discovery and delivery, medical device design and regulatory affairs.

MEK can provide strategic counsel and direction for biotech and life sciences companies to highlight the benefits of new technologies, inform key audiences of validation processes and R&D efforts, and help navigate regulatory complexities in the industry.

MEK also understands how conducting marketing communication campaigns for biotech companies must also be sensitive to and address investor relations issues, including financial reporting and accountability concerning public funds used in research and development.

If you’re in bio-tech, you need a communication partner who understands your business. MEK knows how to position and sustain compelling messages that will build your share of market – and mind.